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Summary 
To determine the mechanism and structural consequences of peptide binding to class I molecules, 
we have studied the L  d molecule of the mouse. Previous studies have shown that a significant 
proportion of surface and intracellular L  a molecules can be detected in an alternative confor- 
mation designated Laalt, Ldalt molecules are non-ligand associated and show weak if any 32- 
microglobulin (32m) association. We report here that L  a molecules have a relatively rapid surface 
turnover compared with other class I molecules and that exogenous peptide dramatically prolongs 
L d surface half-life. By contrast, Laalt molecules are stably expressed on the surface and their 
half-life is unaffected by exogenous peptide. To study the surface interaction of peptide with 
L  a, live cells were incubated with iodinated peptides and L  d molecules were precipitated from 
cells precoated with monoclonal antibody before lysis. Using this assay, peptide binding to surface 
L a molecules was found not to depend upon exchange with exogenous 32m, but did correlate 
with the level of 32m association.  To study the intracellular interaction of peptide with L  d, cell 
lysates were used. In cell lysates, peptide was found to convert Ldalt molecules to properly folded 
L  d. This peptide-induced folding was almost complete at earlier but not later time points in 
pulse-chase  analyses. Furthermore,  conversion  of Ldalt  to  L  d was  found  to  affect  almost 
exclusively immature (Endo H s) class I molecules. Thus intrinsic properties of immature Ldalt 
molecules or their associated chaperonins are maintained in cell lysates that allow them to undergo 
de novo folding in vitro. These combined results demonstrate that immature Laalt molecules 
are precursors awaiting constituents such as peptide and 32m that influence folding, whereas 
surface  Laalt molecules appear  refractory to association  with peptide, 32m,  and consequent 
folding. 
C 
lass I MHC molecules are membrane-bound glycopro- 
teins that function as receptors for peptide ligands which 
are presented to CTL. For example, after infection, cells pro- 
cess virus-derived proteins into short peptides of eight to nine 
amino acids that bind self class I molecules (1-3).  When ex- 
pressed on the cell surface, peptide-class I complexes can iden- 
tify vitally infected cells for destruction by host immune CTL. 
Studies using the drug brefeldin A  (Bfa)  1 suggest that the 
initial binding of peptide by class I occurs in a pre-Golgi corn- 
1 Abbreviations  used in this paper: Bfa, brefeldin A; Endo H, endoglycosidase 
H; ER, endophsmic reticulum; h~zrn, human B2-microglobulin;  LCMV, 
lymphochoriomeningitis  virus; NMS, normal mouse serum; PAS, protein 
A Sepharose; SF, serum-free. 
partment, presumably the endoplasmic reticulum (ER) (4, 
5). Although present dogma dictates that the initial interac- 
tion of peptide with class I is physiologically the most im- 
portant, recent studies have shown that considerable peptide 
binding can occur at the cell surface for at least certain class 
I molecules (6-10).  In spite of recent progress delineating 
the  consequences of the  intracellular  versus  extracellular 
binding ofpeptide by class I, it remains unclear whether they 
are mechanistically equivalent. Furthermore, peptide inter- 
actions have only been studied for a limited number of different 
class I molecules and already several important locus-specific 
distinctions have been noted. Thus, even though there is 
general agreement concerning certain principles governing 
peptide-class I association,  there is also considerable uncer- 
tainty or controversy. 
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class I, recent studies suggest that specific ligands play an 
integral role in the folding of the nascent dass I molecule. 
The initial support for this hypothesis came from studies of 
the RMA.S cell line, a mutagenized cell line immunoselected 
to be class I deficient (11). Indeed, there is considerable in- 
direct evidence indicating that RMA.S has a defect in the 
transport of intracellular peptides (6, 12). At 37~  most of 
the RMA.S class I molecules are sensitive to endoglycosidase 
H  (Endo H), implying that they are ER retained, and most 
cannot be detected by conformation-dependent (i.e., c~1/ol2 
domain) antibodies, implying that they are misfolded or un- 
assembled. Townsend et al. (13) reported that when specific 
Peptide ligands were added to RMA.S cell lysates, properly 
conformed and assembled class I molecules were detected. 
In agreement with this observation, peptide ligands were found 
to specifically facilitate the folding of HLA.B27 molecules 
produced in a cell-flee translation system (14). Even though 
these studies provide strong evidence that peptide influences 
de novo folding of class I, other findings suggest that class 
I molecules can attain functional conformation in the absence 
of peptide. For example, untreated lysates of RMA.S cells 
grown at 37~  contain significant amounts of conformed 
class I molecules and RMA.S cells grown at 25~  express 
high levels of class I molecules recognized by conformation- 
dependent mAb. Thus, peptide may not be an absolute re- 
quirement for de novo folding. Besides Peptide ligand, the 
other known participant in class I folding is Bz-microglo- 
bulin (~/~m). Studies of the Bzm-deficient cell lines DAUDI 
(15) and RIE (16) suggested that intracellular B2m is a req- 
uisite for folding and transport of most class I heavy chains. 
An exception to this rule came from studies of RIE.D b,  a 
/32m-  cell line transfected with the/yo gene under a strong 
viral promoter (17). Surface D b molecules are expressed by 
RIE.D  b cells but remain unassembled and are not recognized 
by conformation-dependent antibodies.  This observation sug- 
gests that ~2m association is not an absolute requirement for 
intracellular transport, a conclusion also supported by recent 
studies of L d (18) and D din6 (19) molecules. However, studies 
of RIE.D b would suggest that intracelhlar B2m is required 
for proper folding. In apparent contradiction of this condu- 
sion, Townsend and colleagues (20) reported that the addi- 
tion of either peptide ligand or B2m to an RIE.D  b lysate 
resulted in the detection of conformed D b molecules. Thus, 
even though both  Peptide and  B2m  dearly influence the 
folding of class I molecules, their separate contributions under 
physiological conditions have yet to be defined and very well 
may differ significantly among class I molecules. 
In regard to the consequences and mechanisms of Peptide 
binding to surface class I molecules, studies of RMA.S indi- 
cate that ligand association is required for stable class I ex- 
pression. RMA.S cells grown at 25~  express what appears 
to be empty class I molecules that, when switched to 37~ 
rapidly become undetected by conformation-dependent  mAbs 
(6, 12). Furthermore, either specific Peptide (11) or mAb (21) 
was found to dramatically and specifically increase the half- 
life of class I molecules expressed by RMA.S. In studies of 
unselected live cells cultured at 37~  with labeled Peptide 
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ligands,  specific binding was observed to L  d (9),  K d (10), 
B27 (7), and D b (8) molecules. These fndings were inter- 
preted as evidence that a significant proportion of these class 
I molecules are expressed at 37~  with empty ligand binding 
sites (7, 10). In routine systems evidence has been provided 
that ~zm exchange may influence Peptide binding at the cell 
surface.  Clearly, the addition of human 32m can facilitate 
peptide binding to murine class I molecules (22-24). How- 
ever, certain mouse class I molecules show a strong propen- 
sity to exchange their own 3zm for either human or bovine 
3~m, and this exchange may facilitate peptide binding at the 
surface. It is therefore unclear whether peptide binds to sur- 
face class I molecules previously conformed by intracellular 
peptide, to open folded class I molecules that have not yet 
encountered Peptide, or to unfolded class I molecules that 
can fold at the call surface. Thus, the mechanism and physio- 
logical significance ofpeptide binding to surface class I is un- 
clear and again may differ significantly among dass I molecules. 
Our approach to investigating the structural and functional 
consequences of the interaction of peptide with class I has 
focused on the L a molecule. The uncharacteristically low 
level of surface expression of L d relative to K d or D a was 
found to the dramatically and specifically increased by cul- 
turing H-2  a haplotype cells with known L a ligands (25). 
This result indicated that a high percentage of L d molecules 
have readily accessible binding sites. Exploiting this feature 
of L d, a binding assay was developed whereby live cells were 
grown with 12SI-labeled  Peptides (9). In these assays, we dis- 
covered a unique mAb,  designated 64-3-7,  that  detects a 
non-peptide associated conformational variant of L a. This 
alternative form of L d, designated Laalt, showed weak if any 
3zm association and was detected both intracellularly and at 
the cell surface (9). In this communication we present data 
indicating that when cells are cultured with Peptide, binding 
occurs to properly folded surface L d molecules and signifi- 
cantly prolongs their half-life. By contrast, when cell lysates 
are incubated with Peptide, binding occurs to immature or 
nascent Ldalt  molecules and facilitates  their conversion to 
proper conformation. These distinctions between the effect 
of peptide on immature vs.  surface L d molecules are dis- 
cussed in the context of other recent studies of class I-ligand 
interaction. 
Materials and Methods 
Cell Lines.  bL  d ceUs were generated by introducing  the L d 
gene into routine Ltk-DAP-3 (H-2  k) fibrobhst cells. All of the cell 
lines used were maintained at 37~  6.5%  COz in DME (Gibco 
Laboratories, Grand Island, NY) containing 10% FCS (Hyclone 
Laboratories Inc., Logan, UT), 2 mM t-glutamine, and 100 U/m1 
penicillin/streptomycin (DME-FCS). In certain experiments, L-L  d 
ceils were grown in serum-free DME medium supplemented with 
1% Nutridoma SP (Boehringer Mannheim Corp., Indianapolis, IN) 
for 3 d before the assays. In other assays ceUs were treated with 
Bfa (Epicentre Technologies, Madison, WI) to block new surface 
expression of class I molecules. Concentrations  between  1 and 
5/~g/ml were used. In data not shown, 1/~g/ml of Bfa was found 
to be su~cient to completely block sialation of L  a molecules. 
mAk  For detection ofL  a molecules mAb 30-5-7 (c~2 domain) 
Differences  in Peptide Binding to Nascent Versus Mature Class I (26), 64-3-7 (cd domain) (27), or 28-14-8 (c~3 domain) (26) were 
used. As control antibodies, 3-83 (K  k, D k) (28), 11-4-1 (K  k) (29), 
and 34-5-8 (D  a) 0 0) were used. All mAbs are of the IgG2 isotype. 
Immunoprecipitation.  Immunoprecipitation of  class I molecules 
with specific mAbs was performed as previously described (31). 
To monitor L d antigenic conformation in biosynthetic lysates  calls 
were labeled with [35S]methionine  and then lysed with 0.5% NP- 
40 in Tris-buffered  saline, pH 7.0, containing freshly added PMSF 
(0.2 raM; Sigma Chemical Co., St. Louis, MO) and supplemented 
plus or minus/32m and/or peptide for 30 rain on ice. Cell lysates 
were incubated overnight at 4~  After overnight incubation, 1y- 
sates were centrifuged at 100,000 g for 1 h and supernatants were 
precleared with an equal volume of 10% (vol/vol) IgGsorb (The 
Enzyme Center, Malden, MA). Samples  of these glycoproteins  were 
next incubated with 0.1 vol of individual mAb asdtes for 30 rain 
on ice, followed by incubation with an equal volume of Protein 
A-Sepharose (PAS) beads for 30 min on ice. The IgGsorb-mAb- 
antigen complexes were washed three times in cold Tris-buffered 
saline containing 1% NP-40 and 0.2 mM PMSE The mAb-Ag com- 
plexes were eluted by incubation of the samples in 0.125 M Tris- 
HC1, pH 6.8, 12.5% glycerol,  2% SDS, and 1% 2-ME (SDS-PAGE 
sample buffer) at 90~  for 2 rain, followed by centrifugation to 
remove PAS. SDS-PAGE was performed on a 10-15% linear poly- 
acrylamide gradient Laemmli buffer system (32). Prestained mo- 
lecular weight standards  (Bethesda Research Laboratories,  Gaithers- 
burg, MD) were induded on every gel. The gds were then treated 
with EN3HANCE (NEN-Dupont,  Boston, MA), dried, and ex- 
posed to X-Omat AR film at  -70~  for 1-10 d. 
For measurements of surface  binding of radioiodinated peptide, 
L-L  d cells were incubated for 4 h at 37~  with l~I-labeled pep- 
tide. Ceils were harvested and washed five times with DME (un- 
supplemented). Each cell sample was resuspended in 500/~1 PBS 
and incubated 30 rain on ice with 0.1 vol antibody. After the incu- 
bation cells were washed three times with DME (unsupplemented) 
and lysed  in 0.5% NP-40/0.2 mM PMSF. Peptide-chss I complexes 
were precipitated with an equal volume of 10% IgGsorb. 
In lysate binding experiments, bL  d cells were detergent lysed 
in 0.5% NP-40/0.2 mM PMSF supplemented plus or minus radio- 
labded peptide ligand. Lysates were clarified by 1 h, 100,000 g, 
4~  centrifugation and incubated overnight at 4~  Glycoproteins 
from these lysates  were purified  by lentil lectin Sepharose  4B (Phar- 
macia Fine Chemicals, Piscataway, NJ) affanity  chromatography 
using 0.5 M cx-methylmannoside  for dution. Samples were in- 
cubated with 0.1 vol mAb for 30 min on ice. IgGsorb was used 
to precipitate class I complexes. 
Flow Cytometry.  Flow cytometry was performed as previously 
described (9). Briefly, 2-4  x  10  s cells were placed in the wells of 
round-bottomed microtiter phtes, washed  once with HBSS (lacking 
phenol red) containing 0.2%  BSA/0.1% sodium azide (FACS  | 
medium), and incubated with a saturating concentration of mAb 
|  o  or with FACS  medium alone for 30 min at 4 C. The cells were 
washed three times with FACS  |  medium and then incubated with 
a saturating concentration of fluorescein-conjugated  F(ab')z frag- 
ment of goat anti-mouse IgG, Fc-speclfic  (Organon-Teknika-Cappel, 
Durham,  NC) for 30 min at 4~  washed with FACS  |  medium 
three times, and finally  resuspended  in FACS  |  medium containing 
10/~g/ml propidium iodide. Fluorescein-hbeled  cells  were analyzed 
using a FACScan  |  (Becton  Dickinson & Co., Mountain View, CA) 
equipped with an argon laser tuned to 488 nm and operating at 
150 mW of power. Fluorescence  histograms were generated with 
logarithmic amplification of fluorescence  emitted by single viable 
cells. Each sample analyzed comprised a minimum of 1  x  104 
cells. Mean fluorescence  values were converted from logarithmic 
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amplification of fluorescence  intensity by linear regression analysis 
using the CONSORT 30 computer software. 
Peptide Synthesis.  Peptides were synthesized using Merrlfield's 
solid-phase  method (33) on a peptide synthesizer (model 431A; Ap- 
plied Biosystems, Inc., Foster City,  CA).  All peptide synthesis 
reagents were of high purity (>99%) and supplied  by Applied Bio- 
systems, Inc. The resin used for peptide synthesis was phenylace- 
tamidomethyl and was prdoaded with 0.5 mM of required amino 
add. All amino acids used were t-Boc protected at the NHz ter- 
minus and their reactive side chains were protected with the stan- 
dard groups recommended by Applied Biosystems, Inc. for t-Boc 
synthesis, with the exception of histidine. The histidine derivative 
used was N-ct-Boc-N-vr-benzyloxymethyl-L-histidine  supplied by 
Bachem (Torrance, CA). The Boc-amino acids were coupled using 
carbodiimide-hydroxybenzotriazole  coupling cycles  as recommended 
by the manufacturer.  The peptides were simultaneously  deprotected 
and cleaved  from the resin by treatment with anhydrous hydrogen 
fluoride/anisole/dimethyl  sulfide 10:1:1 (vol/vol/vol) for 50 min at 
0~  The cleaved  peptide was washed with diethyletber to remove 
organic by-products generated during hydrogen fluoride cleavage. 
The peptide was then extracted from the resin with 30% acetic 
add. The acetic acid was removed by rotary evaporation, and the 
remaining aqueous peptide solution was diluted fourfold with 
H20, shell frozen, and lyophilized. Peptides were purified (~90%) 
by reverse-phase HPLC and subjected to purity assessment tech- 
niques as previously described (34). 
Peptide Labeling.  Peptides  were iodinated using the Iodo-Beads 
(Pierce Chemical Co., Rockford, IL) method. Briefly,  Iodo-Beads 
were washed twice with iodination buffer (100 mM sodium phos- 
phate, pH 7.4). Two Iodo-beads were mixed with 1-5 mCi of 
Na12SI (New England Nuclear, Boston, MA) in 200/~1 iodination 
buffer at room temperature for 5 rain. A solution of 300 #1 of pep- 
tide in iodination buffer was added to the Iodo-Beads  reaction mix- 
ture. The iodination reaction was allowed to proceed for 15 rain 
at room temperature and terminated by removing the reaction mix- 
ture from the Iodo-Beeds. The radiolabeled peptide was recovered 
by transferring the reaction mixture to a 1-ml packed AGI-x8 ion 
exchange resin (Bio-Rad Laboratories, Richmond, CA) column to 
bind the free lzsI. After centrifugation (2,500 g, 5 min) the radio- 
labeled peptide-contaiuing fluid forced through the column was 
collected and stored at 4~  before use. Peptides were labeled with 
specific activities between 0.2 and 1  x  1016 cpm/mol. 
Results 
To define the parameters involved in the association of  ligand 
with class I MHC molecules, we have studied the L  a mole- 
cule of the mouse. Previous studies of peptide-induced surface 
expression of L  a identified a unique mAb designated 64-3- 
7. Whereas expression  of other epitopes was increased two- 
to  fivefold after treatment with different known peptide 
ligands, the epitope recognized by 64-3-7 was unaffected (9). 
Immunoprecipitation studies showed that mAb 64-3-7 defined 
an alternative form of L d (Laalt)  as compared with other 
mAbs  to  L  d (e.g.,  30-5-7).  Laalt  molecules were  distin- 
guished by their minimal, if any,/~zm association and their 
slower rate of oligosaccharide maturation. The intracellular 
ratio of 64-3-7 + to 30-5-7 ~ L  a molecules was found to be 
variable  and generally higher in ceils that overexpress  L d, 
such as the bL  a transfected cell line. In an earlier report (9) 
we measured ligand binding to L  d by culturing bL  a cells or P815  cells  with  12SI-labeled murine CMV  peptide  (pp89, 
168-176) (35). After 4-6 h culture, ceils were lysed in NP-40 
and class I molecules were immunoprecipitated. Whereas 30- 
5-7 precipitates contained high levels of labeled CMV pep- 
tide, 64- 3-7 precipitates contained no specific radioactivity (9). 
This result indicated that Laalt molecules are not ligand as- 
sociated, in contrast to 30-5-7 + L a molecules that demon- 
strated considerable ligand association. To quantitate what 
proportion of the binding in this assay occurred to surface 
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Figure 1.  Comparisons of the binding of CMV peptide to alternative 
forms of L d at the surface versus in cell lysates.  (A) Quantitation  of the 
amount of peptide binding at the surface versus the surface and cell lysate. 
To measure peptide binding to surface L ~ molecules (upper panel),  5  x 
107 LL  d cells were incubated with lzSI-hbeled CMV peptide (1  x  10 -s M) 
at 37~  for 4 h. Cells were then washed three times to remove unbound 
peptide and divided into three groups,  and each  group was treated with 
excess (100 #1 ascites fluid) mAb 30-5-7, 64-3-7, or 11-4-1 as indicated along 
the left of the figure.  After 30 min incubation with antibody on ice, cells 
were washed three times and precipitates were obtained using IgGsorb.  Pellets 
were counted to quantitate the amount of peptide bound to L d, Ldalt, and 
K k molecules, respectively.  To measure surface and lysate CMV binding to 
bL  d cells (,4,/ower panel) the protocol was the same as above except that 
the respective mAbs (100/A ascites) were also added after cell lysis. (B) CMV 
peptide binding in ~  lysate~ 10  x  106 Ltk- DAP3 cells were incubated 
with  150 #g radiohbeled CMV peptide at 37~  for 4 h,  washed exten- 
sively, lysed,  and mixed with an equal number of mock-treated DL  d cells. 
The lysate (500/A, 0.5% NP-40) was incubated overnight at 4~  Peptide- 
associated  counts were precipitated with antibodies to class I and IgGsorb 
(bottom panel). The reciprocal experiment was similarly performed (top panel). 
(C) CMV peptide binding in cell lysates. 4  x  107 DL  d cells grown at 37~ 
were lysed in 2 ml 0.5% NP-40 containing 160/~g of hbeled CMV peptide. 
The lysate was incubated overnight at 4~  and then divided into four equal 
parts.  Each aliquot was treated with a saturating concentration of mAb 30- 
5-7 (ot2Ld), 28-14-8 (cx3Ld), 64-3-7 (Leak),  or 3/83(KkD k) and lgGsorb to 
precipitate class I molecules. 
L d molecules, the experiment shown in Fig.  1 A  was per- 
formed. L-L  d cells were incubated with mI-CMV peptide for 
4 h, after which time they were treated with an excess amount 
of mAb 30-5-7 (anti-La), 64-3-7 (anti-Laalt),  or 11-4-1 (anti- 
Kk).  After extensive washing, half of each of these mAb- 
coated cells were lysed in NP-40 and Ab-class  I complexes 
were precipitated. Precipitates were then counted to deter- 
mine the amount of peptide bound to surface class I mole- 
cules. Under these conditions no Ab/La/peptide dissociation 
was observed in the lysate as determined by using excess com- 
petitors (data not shown). As shown in the upper pand of 
Fig. 1 A, of the three mAbs only 30-5-7 precipitated significant 
peptide-specific counts. The other half of the antibody-coated 
bL  a calls were lysed and each lysate was treated again with 
the same respective mAb. Thus, predpitates from these samples 
should include surface and intraceUular class I molecules with 
bound peptide. As shown in the lower panel of Fig.  1 A, 
only 30-5-7 precipitates again contained peptide-specific counts. 
Comparisons of the amount of peptide binding observed by 
surface versus surface plus lysate precipitate indicate that 80% 
of the peptide binding can be accounted for by surface 30- 
5-7 +  L a  molecules.  The  remaining  20%  of the  peptide 
binding could either have occurred intracellularly or in the 
lysate. To quantitate the amount of binding that can occur 
in a lysate,  the mixed-lysate experiment shown in Fig.  1 B 
was performed. As a positive control a lysate from bL  d cells 
that were fed t~SI-peptide was mixed with a lysate of Ltk- 
cells. As expected, significant specific peptide binding to 30- 
5-7 + L d was observed (Fig.  1 B, upper  panel). In a reciprocal 
experiment, a lysate of unfed L-L  d ceils was mixed with a 
lysate of CMV-fed Ltk- ceils. In this mixture, binding to L d 
could only occur in the lysate because Ltk- cell are L  d nega- 
tive.  As shown in the lower panel of Fig.  1 B, a small but 
specific amount of lysate binding to L d was detected. Com- 
parison of the amount of peptide binding measured in these 
reciprocal experiments (Fig.  1 B) indicates that only 5% of 
the binding to L d occurred in the lysate when bL a cells was 
cultured with labded peptide. Thus, using this assay system, 
most of the binding clearly occurs to surface L a molecules 
before cell lysis. 
Although the above experiments indicate that culturing 
ceils with peptide results in binding to predominantly sur- 
face L d molecules, they also suggest that binding to L d can 
occur in cell lysates  (Fig.  1 B).  To better characterize this 
latter binding, a lysate of L-L  a cells was incubated with t25I- 
labeled CMV peptide. As shown in Fig.  1 C, anti-L  d mAbs 
30-5-7 and 28-14-8 precipitated significant peptide-bound mol- 
ecules in contrast to 64-3-7  precipitates that contained no 
counts above background. In data not shown, comparable 
results were obtained with another known ligand for L a de- 
rived from the lymphochoriomeningitis virus (LCMV) nu- 
cleoprotein (NP 118-126) (36). To define the relationship be- 
tween  alternative forms  of L d,  various  concentrations of 
peptide ligand plus or minus human 32m (h/32m) were in- 
cubated with aliquots of biosynthetically labeled L-L  a lysates. 
Peptide treated lysates exhibited a dramatic, dose-dependent 
increase in  30-5-7 +  L a  molecules in  conjunction  with  a 
proportional decrease in 64-3-7 + L d molecules (Fig.  2 A). 
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Figure 2.  Treatment  of L-L  d cell lysates with CMV peptide and/or h/Szm 
converts 64-3-7 + L  a to 30-5-7  + L  d. (A) Dose dependency of the effect of 
Ix'pride on the 64-3-7  + and 30-5-7  + forms ofL  a. 1.6  x  10  s L-L  d ceils were 
labeled with  [3sS]methionine for 3  h,  sohb'dized  in  0.5%  NP-40,  and 
divided into eight  aliquots of 2  x  107 cells. Each aliquot (500/~1, 0.5% 
Nla-40) was incubated at 40C overnight with 3/xM h~zm (Sigma Chem- 
ical Co.), 3/~M la~zrn and CMV peptide, or CMV Ix'pride alone (ix,  pride 
concentrations indicated along top of figure). L  a molecules were precipi- 
tared with saturating amounts of mAb 64-3-7 (top row) or 30-5-7 (bottom 
row) and analyzed by SDS-PAGE. Only class I heavy chains are shown. (/3) 
Quantitative comparisom of the reciprocal effect of peptide on 64-3-7  + L  d 
(11) versus 30-5-7 + L  d (0). The precipitable counts shown were obtained 
from the samples analyzed in the first four lanes ofA. (C) Peptide induction 
of 30-5-7  + L  d in lysates precleared with mAb 30-5-7. Aliquots of an LL  a 
lysate were precleared two times using PAS beads coated with either 30-5-7 
(bottom  pane/) or 34-5-8 (top  pane/) used as an irrelevant control. Precleared 
lysates were aliquoted (2  x  107 bLa, 500/xi, 0.5% NP-40) and incubated 
overnight at 40C with hlSzm (3/~M)  or CMV peptide (400/zg) or left 
untreated (as indicated along the right side of figure). Samples were precipi- 
tated with saturating amounts of mAb 30-5-7, 64-3-7, or 34-5-8 (as indi- 
cated along the top), along with PAS. Precipitates were resolved by SDS- 
PAGE and only class I heavy chains are shown. 
This  crisscross  relationship  between  64-3-7 +  L a  and  30-5- 
7 +  L a molecules  is  graphically  represented  in  Fig.  2  B.  In 
the same experiment,  addition of purified l~2m alone or to- 
gether with peptide was found to shift the ratio of the two 
forms  toward  30-5-7 +  L a  (Fig.  2  A).  The  addition  of the 
LCMV  peptide  to an L-L  a cell lysate was  also  found  to  in- 
crease  30-5-7 +  L a  and  decrease  64-3-7 +  L a,  whereas  an  ir- 
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rdevant  peptide  had no effect (data not shown).  To directly 
test whether 64-3-7 + L a molecules could be converted to 30- 
5-7 +  L a molecules,  a lysate was  selectively precleared  of all 
30-5-7 +  L a molecules  and subsequently  treated with h/3zm/ 
peptide.  New  30-5-7 +  L a  molecules  were  detected  in 
hB2m/peptide-treated  lysates  but  not  untreated  controls 
(Fig.  2  C).  This  experiment  formally  established  the Figure 3.  Pulse-chase  experiment demonstrating that predominantly immature (Endo H') forms of L  d glycoproteins  are susceptible to peptide-induced 
conformational change. (A) Biosynthetically  hbeled bL  a cells were pulsed for 15 m and chased for 0, 4, or 6 h as indicated along the bottom of the 
figure. Lysates (2  x  10  r DL  a, 500 #I, 0.5% NP-40) from each chase period were incubated overnight (4~  with or without h132m (3/zM) and CMV 
pepdde (40/~g). Class I molecules were precipitated with mAbs 64-3-7 and 30-5-7 and resolved by SDS-PAGE. Using this gel system, mature (Endo 
H  r~) and immature (Endo H+) class I molecules resolve into two separate bands as indicated. (B) Densitometric tradng of the class I precipitin bands from 
the 6-h chase period shown in Fig. 3 A. For comparison, the profiles of the control (  ) and hBzm/peptide-treated (  ....  ) are superimposed. 
precursor-product relationship between 64-3-7 + L a and 30- 
5-7 +  L a.  In conjunction with  the  aforementioned  proper- 
ties of Ldalt, these findings demonstrate that 64-3-7 uniquely 
detects nonconformed L a molecules capable of binding pep- 
tide ligand.  To better characterize the L d molecules suscep- 
tible to antigenic conversion, pulse/chase experiments were 
performed. Even though 64-3-7 + Laalt molecules are trans- 
ported more slowly than 30-5-7 + L d molecules,  after a 4-h 
chase time  mature  (Endo H v') forms of both  are detected. 
As shown in Fig. 3 A, L a molecules were decreasingly sus- 
ceptible to peptide/hB2m-induced conversion with increased 
time  of chase.  At  the 0  time point  ~80%  of the 64-3-7 + 
L a molecules were convertible to 30-5-7 + Ld; after 4 and 6 h 
that percentage dropped to 50 and 40%,  respectively.  Fur- 
thermore,  Endo  H'  forms  were  preferentially  affected  by 
peptide/hB2m treatment as observed in both the loss of im- 
Figure 4.  Pulse-chase experiment demonstrating that peptide alone is as effective  as peptide and hB2m in inducing Endo H  +  forms of 30-5-7* L  d. 
(A) Biosynthetically  labeled I..L  a cells were pulsed for 15 m and chased for 0 or 4 h as indicated. Respective lysates (1.25  x  10  r bL  a, 500/~1, 0.5% 
NP-40) were divided and treated overnight with CMV peptide (40/zg), h~2m (3/zM)  +  CMV (40/zg) peptide, or untreated control. L  a molecules 
were precipitated with mAb 30-5-7 and half of  each precipitate was digested with Endo H (+) (1 mU/ml; ICN ImmunoBiologicals,  Lisle, IL), whereas 
the other half was mock digested (-). Precipitates were resolved by SDS-PAGE. (B) Densitometric tracing of the precipitin bands from the 4-h chase 
period shown in A. For comparison, the profiles of the control (  ) and peptide-treated (  ....  ) are superimposed. 
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(Fig. 3 B). A  second important feature of this experiment 
is that nearly all 30-5-7 + L  a molecules exchange mouse for 
hfl2m. Compared with control lysates, hfl2m/CMV-treated 
lysates undergo significant or complete exchange of exoge- 
nous cold hfl2m for endogenous-labeled fl2m  (Fig. 3 A). 
This result was also obtained with hflzm treatment alone 
(data not shown). To substantiate the observation that im- 
mature 64-3-7 + L  d molecules are preferentially affected by 
peptide/hfl2m  treatment, a pulse-chase experiment was per- 
formed using Endo H  digestion to formally define imma- 
ture molecules (Fig. 4 A). In this experiment peptide or pep- 
tide/hfl2m resulted in the comparable induction of 30-5-7 + 
L d molecules (a 90%  increase  at time 0 versus  a 50%  in- 
crease at time 4 h), implying that hfl2m exchange is not re- 
quired for peptide-induced folding of L  a in cell lysates. Fur- 
thermore, the affected molecules are clearly sensitive to Endo 
H  digestion. As shown in Fig.  4 B densitometric tracings 
of 30-5-7 precipitates from the 4-h time point indicate that 
the peptide-induced 30-5-7 + L  d molecules were exclusively 
immature (Endo H s)  forms. Thus,  this in vitro antigenic 
conversion of L  d molecules accurately mimics in vivo folding 
of nascent L d molecules, demonstrating that intrinsic prop- 
erties  of immature  class  I  molecules  or  their  associated 
chaperonins are maintained in vitro in cell lysates. 
To determine the effect of peptide on expression and sur- 
face turnover of L  a forms, IcL  d cells were grown with pep- 
tide and/or Bfa (a drug that prevents new surface expression 
of class I). The expression  of 30-5-7 + L  a was dramatically 
increased by peptide treatment alone in that a threefold in- 
crease was observed during the 6-h incubation (Fig.  5 A). 
The maintenance of the high level of expression  of peptide- 
induced L  a was dependent upon new arrival of L  a molecules 
at the cell surface as shown by comparing cells treated with 
peptide alone versus Bfa plus peptide (Fig.  5 A). However, 
it can also be seen that peptide has a substantial effect on 
L a  surface  stability by comparing  cells  treated  with  Bfa 
versus Bfa plus peptide. 30-5-7 + L  a molecules were rapidly 
turned over (tl/2 "~2 h), but peptide greatly extended their 
half-life (tv2 >6 h). The rapidity with which L  d is turned 
over is in contrast to other class I molecules tested such as 
K k (Fig.  5 C) or D d (data not shown) that have half-lives 
;>6 h. Unexpectedly, 64-3-7 + Ldalt molecules were found to 
be stably expressed on the cell surface (tl/2 ~6 h) (Fig. 5 B). 
In the assay shown in Fig. 5, peptide decreased  the 64-3-7 
expression. As previously reported,  the magnitude of the 
peptide-induced decrease in 64-3-7 + L  d varies considerably 
among assays or cell types with certain assays showing no 
decrease in 64-3-7 + L  ~ in spite of considerable increases in 
30-5-7 + L  a expression (9). Although the nature of these dis- 
parities in 64-3-7 + L  a expression with peptide are unclear, 
what is apparent is that the turnover of 64-3-7 + L  a is largely 
unaffected by peptide. This conclusion is supported by data 
shown by the comparisons of  Bfa versus Bfa +  CMV peptide- 
treated cells (Fig. 5 B). This result suggests that peptide does 
not induce a significant proportion of 64-3-7 + L  d molecules 
to convert to 30-5-7 + L  d at the surface; nor does peptide ap- 
pear  to  prevent  surface  30-5-7 +  L a  molecules  from 
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Figure 5.  Comparison  of the peptide  inducibility  and surface  turnover 
of alternative  forms of L  d on bL  d cells, bL  d cells (5  x  10S/ml)  were in- 
cubated with 10 -4 M CMV peptide (Q), medium  (X), Bfa (A), or Bfa 
plus 10 -4 M CMV peptide ([7) for a period of 0, 2, 4, or 6 h. After  pep- 
tide and/or Bfa treatment IcL  a cells were stained with mAb against L  a 
(30-5-7)  (A), Ldalt (64-3-7) (B), or  Kk(11-4-1) (C), respectively. 
Quantification of class I surface expression on these cells was analyzed 
by cytofluorometry  on a FACScan  |  Mean fluorescence  values were  con- 
verted from logarithmic  amplification  of fluorescence  intensity  by linear 
regression analysis. 
"melting" to 64-3-7 + L  d.  Either of these above  scenarios 
would have predicted that in the presence ofBfa, peptide would 
cause  a  significant decrease  in  64-3-7 + L  a expression.  By 
contrast, peptide dramatically increased expression of 30-5- 
7 + L  a in the presence  of Bfa (Fig.  5 A). Thus, in spite  of 
the near-complete conversion of 64-3-7 + L + to 30-5-7 + L  a 
in cell lysates, no measurable conversion was detected on the 
cell surface. The failure to detect conversion of cell surface 
64-3-7 + L  d was also noted in experiments where bL  d were 
surface iodinated, detergent lysed, and incubated overnight 
with peptide (data not shown). Thus, the distinction between 
alternative forms of L a appears to be fixed intraceUularly and 
is relatively irreversible  at the cell surface. 
To better quantify the factors controlling the extracellular 
binding of peptide, direct binding of lzSI-labeled CMV to 
surface L  a was measured after cells were cultured under var- 
ious conditions. In the experiment shown in Fig. 6 A, bL  a 
cells were tested in a 4-h assay for their ability to bind pep- 
tide in media containing FCS, FCS +  Bfa, serum flee (SF), 
or SF  +  hB2m.  Specific binding to surface L  d was deter- 
mined by precoating cells with mAb before lysis (method 
detailed in the legend of Fig. 1). Precipitates  of 30-5-7 + L  d 
from cells grown with Bfa were found to contain about half 
as many peptide-specific counts as precipitates from cells grown 
in FCS. This reduced binding could clearly be accounted for 
by the  reduced L a expression  after 4  h  in  Bfa (data  not 
shown). Thus, peptide binding to L d is not dependent upon 
new arrival of L  ~ molecules to the cell surface. When cells A  Surface CMV binding to L-L  d cells in: 
0  2  4  6  8  10 
Surface CMV  binding to L-L  d calls grown in: 
10%  FCS  LLa,,it ~ 
~L  d  ~,////////.//////~,f/~//~Lf/~//j///~/.~xr 
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C  Surface  CMV  binding  to L-L  d cells in serum free media with: 
Sfa  LLdalt 
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Figure 6.  Surface  CMV binding to I.-L  d cells ~n  under various con- 
ditions. All binding  assays  were  performed  at 37~  as detailed  in Materials 
and Methods. (.4) Binding  of CMV peptide to DL  d cells grown in FCS 
(10%), FCS (10%) plus Bfa, SF, or SF plus hBzm (18 pg/ml). After  cul- 
turing cells with peptide for 4 h, binding  to surface  L  d or K  k molecules 
was assessed  by precoating cells before lysis  with mAb 30-5-7 or 11-4-1, 
respectively. This method is described in detail in the legend of Fig. 1 
A. Cells used for the assay  shown in A were previously  maintained  in 
DME  +  10% FCS. (/3) Binding of CMV peptide to bL  d cells grown 
in 10% FCS, 1% FCS, or 1% NMS. In this assay,  cells  were grown  under 
the indicated  conditions  for 3 d before  the binding  assay  as well as during 
the 4-h binding assay. ~ptide binding to surface  L  d or Ldah mohcules 
assessed  by precoating  cells  before  lysis  with mAb 30-5-7 or 64-3-7, respec- 
tively. (C) Binding  of CMV peptide to L-L  a cells grown  in SF media  with 
Bfa, Bfa + 0.5/~g/ml hBzrn (Calbiochem Corp. La Jolla, CA), or Bfa 
+ 5/~g/ml h~zm (Calbiochem  Corp.). In this assay  cells were cultured 
in SF media  for 3 d before  the binding  assay  and were  cultured  under  indi- 
cated conditions  during the binding assay.  Binding  to surface  L  d or Laalt 
molecules was assessed  by precoating cells before lysis  with mAb 30-5-7 
or 64-3-7, respectively. 
were  incubated in  SF  media with labeled-CMV peptide, 
significant binding to surface L d was observed  (85% of the 
FCS control). This result indicates that exchange for exoge- 
nous ~2m appears not to be the major factor in determining 
surface binding to L  d. It should be noted that the cells used 
for the assay shown in Fig. 6 A  were grown in media con- 
taining 10% FCS before their 4-h incubation with labeled 
peptide under indicated conditions. Thus, entering the pep- 
tide binding assay the surface L  d molecules would be ex- 
pected  to  be  heavily  B2m  associated.  Interestingly,  the 
purified hBzm  augmented  the  binding  of peptide  in  SF 
media,  probably by  maintaining a  higher  level  of ~2m- 
associated  L  d during the 4-h assay. 
To further explore the role of B2m association  in peptide 
binding to L  d, L-L  d ceils were grown for 3 d in either 10% 
FCS, 1% FCS, or 1% normal mouse serum (NMS). In our 
previous immunoprecipitation studies (18), surface 30-5-7 + 
L  d molecules were  detected as  predominantly free  heavy 
chains when cells were grown in NMS as compared to het- 
erodimers with bovine B2m when grown in FCS.  In spite 
of these imposed differences in B2m-association, the amount 
of 30-5-7 + L  a and the ratio of 30-5-7 + L  d to 64-3-7 + L  d was 
comparable on cells grown in 10%  FCS,  1%  FCS or 1% 
NMS (fluorometric data not shown). However, the ability 
of cells under each of these conditions to bind peptide was 
clearly different (Fig. 6 B). Correlating with their expected 
level of B2m association  (18), peptide binding to surface L  a 
was highest on cells grown in 10%  FCS,  next highest on 
cells grown in 1% FCS, and lowest on calls grown in 1% 
NMS.  As an alternative method to assess the role of B2m 
association,  bL  a cells were grown in SF medium for 3 d be- 
fore the binding assay in order to maximize/32m dissocia- 
tion and to  eliminate the potential to bind bovine/32m. 
After growth in SF, cells were treated with Bfa to prevent 
new L  d expression during the binding assay. During the 4-h 
incubation with peptide, aliquots of these cells were grown 
with no B2m, 0.5/zg/ml hB2m, or 5 #g/ml hBzm as indi- 
cated in Fig. 6 C. Precipitates  from the control cells with 
no exogenous B2m showed a small but significant amount 
of peptide binding to 30-5-7 + L  d. This binding could be at- 
tributed to either surface expression  of intracellular La432m 
complexes beyond the Bfa block or the failure of all L  a mol- 
ecules to dissociate  in SF media. In any case, the addition 
of purified hBzm to SF media was found to greatly enhance 
the specific peptide binding to L d (Fig. 6 C). In total, these 
experiments measuring direct peptide binding indicate that 
new surface expression  of L  d and exchange for exogenous 
B2m are not required for peptide binding (Fig. 6 A). How- 
ever, when new expression  is blocked and cells are grown 
for an extended period without serum, peptide binding in 
the absence of exogenous/32m was '~22% that seen in the 
presence of hB2m (Fig. 6 C). It is noteworthy that this 22% 
binding did not occur in the lysate since all the assays shown 
in Fig. 6 were performed using Ab-coated cells to detect ex- 
clusively surface class I molecules. What is strikingly apparent 
from each of the experiments shown in Fig. 6 is that peptide 
binding correlates  precisely  with the amount of/32m as- 
sociated with L  d, implying that mainly class I:B2m heterodi- 
mers bind peptide. 
Discusslon 
Several recent publications have studied the association of 
class I molecules with peptide by culturing live cells in media 
containing known peptide ligands (6-10).  The initial experi- 
ments monitored pepdde association indirectly by quantitating 
the peptide-induced increase in surface class I expression. Cul- 
turing cells with peptide resulted in the specific increase of 
class I molecules on immunoselected cells such as RMA.S 
(11) or LBL721.174  (37)  or of L  a (25)  molecules on un- 
selected cells. The mechanism of this induction was origi- 
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the ER. Therein, the fed-peptide would facilitate the folding, 
assembly, and/or transport of the class I H chain. Consistent 
with this notion, immature (Endo H s) class I H chains were 
affected by peptide feeding. However, a subsequent experi- 
ment by Townsend and colleagues (13) showed that peptide- 
induced folding of class I could have occurred in the cell ly- 
sate and not in the intact live cells. Thus, there was no need 
to hypothesize retrograde peptide transport.  Furthermore, 
the observation that peptide stabilized class I expression on 
RMA.S  cells provided a viable mechanism to explain the 
surface increase in class I expression by peptide. In accordance 
with  this conclusion, we report here that peptide ligands 
significantly prolong the half-life of the uncharacteristically 
labile surface L d molecule. Therefore, peptide-induced class 
I expression on live cells certainly affects surface molecules 
and needs not implicate retrograde peptide transport. 
Inspired by these earlier peptide-feeding protocols, several 
groups have incubated various cell types with labeled pep- 
tide ligands for different class I molecules. Specific binding 
was then measured by immunoprecipitating the class I mole- 
cules from the lysates of the peptide-fed cells (6-10). Although 
each of these reports provides direct evidence for specific pep- 
tide binding to class I, in none of these studies was the mech- 
anism elucidated. Mechanistic dilemmas were encountered 
due to two findings: first, cell inhibitory drugs such as Bfa, 
cycloheximide,  or  sodium  azide  have  frequently  yielded 
equivocal results; and second, the aforementioned findings 
of Townsend raised questions of whether binding occurs to 
intact cells or in the cell lysate. Two experiments reported 
here are relevant to this issue. Reciprocal lysate mixtures from 
peptide-fed versus unfed, Ld-positive versus La-negative cells 
were used to quantitate the amount of binding occurring in 
a lysate. This experiment indicated that at most 5% of the 
peptide binding occurred exclusively in the lysate of peptide- 
fed cells.  This finding is in agreement with similar results 
obtained in studies of B27 (7). As an alternative approach, 
cells previously incubated with iodinated peptide were coated 
with mAb before lysis  and thus only surface L a molecules 
were detected.  Using this approach,  surface L d molecules 
could be shown to account for at least 80% of the total (sur- 
face  +  lysate) peptide binding. We therefore feel confident 
that at least in our system most of the peptide ligand binding 
occurs to surface L a molecules on live intact cells. Using this 
assay system we go on to show that the binding of ligand 
to surface L a does not require new expression of class I nor 
exchange  for  heterologous  B2m.  However,  without  both 
new  expression  of  L d  and  exogenous  fl2m,  the  peptide 
binding  to  L d  falls  off  precipitously.  Furthermore,  this 
binding capability can be restored by adding purified hB2m. 
The reduced but  significant peptide binding to L a in the 
presence of Bfa agrees with a recent study of B27 (7),  and 
the observation of significant peptide binding to L a in the 
absence of exogenous ~2m is consistent with studies of D b 
(8) and B27 (7). It should be noted, however, that these latter 
studies did not quantitate ligand binding with or without 
exogenous ~2m.  Perhaps the most striking feature of our 
data is that there is a precise quantitative correlation between 
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the amount of ~2m association and the ability to bind pep- 
tide. We thus conclude that ~/zm exchange is not a prereq- 
uisite for peptide binding to surface class  I, but that B2m 
association promotes binding. 
It has been speculated that ligand binding is to empty class 
I molecules in these assays using live cells.  Indeed, there is 
good suggestive evidence supporting this conclusion from 
studies using RMA.S.  In functional studies, RMA.S cells 
grown at 25~  were found to express high levels of surface 
class I molecules incapable of presenting endogenous antigens 
to CTL (12).  Furthermore, in structural studies these class 
I molecules expressed by RMA.S at 25~  were found to bind 
labeled-exogenous  peptide  ligands  and  were  found  to be 
thermo-labile at 37~  in the absence of exogenous peptide 
(12).  Thus, these studies provide structural and functional 
evidence consistent with the notion that class  I molecules 
expressed by RMA.S cells grown at 25~  are empty. Given 
the validity of this conclusion, it is tempting to speculate 
that L d molecules may also have a propensity to be expressed 
with empty ligand binding sites. Like RMA.S-expressed dass 
I molecules, surface binding of peptide to L a can be readily 
demonstrated and exogenous peptide dramatically enhances 
the  surface stability  of L d.  In  addition,  culturing cells at 
23-26~  substantially increases 30-5-7 + L a expression 1.5- 
to 4-fold, in contrast to other dass I molecules that showed 
modest if any increases (W-K. Lie, unpublished observations). 
However,  under SF conditions 30-5-7 +  L d are  stably  ex- 
pressed and at levels equal to normal serum conditions. This 
result  is  in direct  contrast  to  the extremely labile Kb/D b 
molecules expressed by RMA.S cells at 25~  under SF con- 
ditions (38).  Therefore our data favor the contention that 
at 37~  30-5-7 + L a are occupied by endogenous peptides. 
The unique inducibility of L a at 25~  or with peptide 
ligand could imply that there is a smaller pool of endoge- 
nous peptides capable of binding L d compared with other 
class I molecules. It should be noted that in functional studies 
the L a molecule has been found to be the restriction element 
for several CTL responses (35, 36, 39-42). Thus, these puta- 
tive differences in the ability of L a to bind peptide do not 
impair its physiological function. Perhaps the weak affinity 
of L a for mouse B2m causes it to be more selective in ligand 
binding than other class I molecules. In support of the unique- 
ness of the interaction of nascent L a molecules with Bzm, 
we report here that La-peptide complexes readily exchange 
mouse ~2m for h~2m in cell lysates.  By contrast, Townsend 
et  al.  (13)  found that Db-peptide complexes retain  mouse 
~2m in RMA.S cell lysates.  In agreement with their studies, 
we found that the de novo folding of L a molecules in cell 
lysates was highly influenced by peptide ligand. Given this 
result it is possible that all 30-5-7 + L d molecules synthesized 
at 37~  initially contain (or require) a peptide to attain proper 
folding.  However,  once folded the weak  affinity for B2m 
could render L a more vulnerable for peptide exchange. 
Perhaps the most intriguing result presented in this study 
is  the ambivalent nature of the 64-3-7 + form of L a.  Our 
studies of cell lysates show that peptide converts immature 
64-3-7 +  L d to  30-5-7 +  L a,  clearly establishing  their pre- 
cursor/product relationship. Furthermore, this conversion is extensive if not complete for nascent 64-3-7 + L d molecules. 
By contrast, our attempts to convert mature or surface forms 
of 64-3-7 + L d to 30-5-7 + L d have been unsuccessful. These 
failures  to see conversion were observed in: (a) fluorometric 
comparisons  of surface L d forms on cells treated with Bfa 
+/-  peptide (Fig.  5),  (b) fluorometric analysis  of sodium 
azide-treated cells +/-  peptide ligand (data not shown), (c) 
cells grown in SF media  +/-  purified ~  (Fig. 6, data not 
shown),  and (d) immunoprecipitates  of surface 12SI-labeled 
L a forms treated  with  peptide in  the cell lysate (data  not 
shown).  No evidence for conversion was observed in each 
of the above experiments,  suggesting that unlike immature 
64-3-7 + L d, mature forms are refractory to peptide-induced 
folding. Furthermore, direct evidence showing that only im- 
mature  forms of L d are peptide convertible was shown in 
pulse-chase experiments  (Figs.  3 and 4). 
These characterizations  of the 64-3-7 + L a molecules pre- 
sent some interesting  comparisons in regard to previous reports 
of denatured heavy chains detected in/on cells. In studies using 
lysates of RMA.S, nascent heavy chains were detected by ei- 
ther a mAb to the c~3 domain (e.g., 28-14-8,  [o~3] Db), or 
a  heteroantiserum  to  a  cytoplasmic  domain  of K b  (43). 
These latter reagents, in contrast to 64-3-7, detect both non- 
conformed and conformed heavy chains. Carrying this analogy 
with RMA.S further, one might predict that surface 64-3-7 
is equivalent to melted class I molecules on RMA.S. How- 
ever,  this  appears  not  to be the case.  Melted surface class 
I molecules on RMA.S can only be stably detected with the 
aforementioned  heteroantiserum  and not  ol3 domain anti- 
bodies,  whereas  64-3-7 +  L d molecules  stably  express  o~3 
serological epitopes (e.g., 28-14-8).  More importantly, there 
is considerable evidence that conformed class I molecules on 
RMA.S melt and become detectable with this heteroantiserum 
(21), whereas we have no evidence suggesting that conformed 
L a molecules melt and become detectable with mAb 64-3- 
7. If 64-3-7 + L a were melted 30-5-7 + L d, then adding pep- 
tide to Bfa-treated cells,  adding h~2m to cells in SF media, 
or growing cells at 25~  would be expected to retard melting, 
leading to decreased amounts of surface 64-3-7 + L a. How- 
ever, no reductions were seen in these experiments. Perhaps 
the implication  of the studies of RMA.S is that  the truly 
melted form of surface L a cannot be detected by either 64- 
3-7 or 28-14-8, but only by reagents like the heteroantiserum 
to the cytoplasmic domain.  The better analogy for surface 
64-3-7 + L a is the D b molecule expressed by the ~2m- cell 
line RIE. RIE.D  b and 64-3-7 + L d share several properties in- 
cluding: (a) their detection with c~3 domain mAb, (b) their 
lack of Bzm association,  and (c) an undefined function.  In 
addition,  we found the RIE.D  b molecules like 64-3-7 + L d 
are stably expressed on the surface (h/2 •6  h) and are not 
readily convertible to proper conformation with exogenous 
32m and/or peptide ligand (data not shown). These findings 
imply that  the fates of both 64-3-7 + L d and D b expressed 
by RIE were determined  intracellularly. 
Based on the findings reported here and these comparisons 
to studies of RMA.S or RIE.D  b cells, we propose that struc- 
tural distinctions between the alternative forms of L d are de- 
termined by whether or not peptide//3~m-induced  folding 
occurs. Furthermore,  there is a critical time frame in which 
this folding must occur, as indicated by our pulse-chase ex- 
periments.  The results imply either  that  the ER microen- 
vironment  is required for proper folding or that  structural 
features  of nascent  L d molecules,  or  their  associated pro- 
teins,  render them more susceptible to peptide/3zm-induced 
folding. What is remarkable is that these properties are main- 
tained  in  cell lysates.  Once  64-3-7 +  L d molecules  are ex- 
pressed on the cell surface they appear structurally inert.  In 
contrast,  surface  30-5-7 +  L d molecules  that  are  32m  as- 
sociated readily bind exogenous peptide ligand. 
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